Rolf Müller

Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound

Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use

Cell-specific gene therapy using as promoter novel promoters for tissue inhibitors of metalloproteinase-3

Liposomes and liposomal compositions for vaccination and drug delivery

Nucleic acid construct for the cell cycle regulated expression of structural genes

Use of pairs of leucine zipper peptides in immunoassay methods

Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle

Cell cycle regulated repressor and DNA element

Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle

Multifunctional ligand system for cell-specific transfer of nucleic acid